Wednesday, 18 Oct 2017

PsA/SpA

Datesort ascending Type Title Save
18 Jul 2016 Slide of the day Clinical Associations with Uveitis
18 Jul 2016 Social MTX in PsA yields min. Dz activity in <20%. MDA=5/7 SJC, PASI, entheses≤1, BSA≤3%, HAQ≤0.5, pt global≤20, Pt pain≤15 https://t.co/dO6qyys8yy
14 Jul 2016 Social in 428 SpA pts, BMI (obesity) has no effect on ASDAS. BMI weakly correlates w/ CRP, other PRO's. https://t.co/FcTfEicYpN
27 Jun 2016 Social RAPID3 gives similar outcome info to BASDAI and ASDAS in a cross sectional study of 85 AS patients https://t.co/uIfXJpB5s3
25 Jun 2016 News AS Diagnosis Linked to CVD Risk
17 Jun 2016 Social Swedish registries show (like RA) ankylosing spondylitis is assoc w/ 30%–50% increased risk of incident CV events. https://t.co/9B8CSxOEYi
13 Jun 2016 News No Increased Risk of Colitis Flares in Secukinumab Trials
12 Jun 2016 Social Drs Braun & van der Heidje review efficacy & imaging benefits of Cosentyz & Xeljanz in Ank Spondylitis at #EULAR2016 https://t.co/gM26e2x57t
08 Jun 2016 Social Secukinumab data presented at EULAR; Novartis plans H2H trial of Cosentyx & Humira; details to follow https://t.co/zjA8Rgw0cX
08 Jun 2016 News EULAR: Tofacitinib Effective in Ankylosing Spondylitis
27 May 2016 Social Review of 164 SAPHO pts. Most common:palmoplantar pustulosis > severe acne, Chest wall pain > LBP, 70% ^CRP, 2% B27+ https://t.co/0XpunVdbr0
19 May 2016 Social @DrPetryna Calprotectin (stool or serum) a biomarker in IBD, used to identify bowel inflammation in SpA patients https://t.co/FEuNQ9284c
12 May 2016 News Secukinumab Improves Patient-Reported Outcomes in Psoriatic Arthritis (FUTURE 1)
12 May 2016 Social CORRONA & NPF sign on for a postmarketing safety registry of >4000 Psoriasis pts on Taltz (ixekizumab) https://t.co/ArewqKAZax
09 May 2016 Social Genetic overlap betw anklyosing spondylitis & IBD shown in exom sequencing of 4602 AS patients; Philip Robinson etal https://t.co/E8Tr49X8DV
05 May 2016 Social Spondyloarthritis & Psoriatic arthritis pts (from ARTIS & DANBIO) show NO cancer risk & TNFi does not augment this. https://t.co/cZWccg5gkQ
05 May 2016 News Methotrexate Yields No Added Benefit in Etanercept Treated Psoriatic Arthritis Patients
02 May 2016 Social Health Canada approves secukinumab for use in psoriatic arthritis and anklylosing spondylitis https://t.co/TmmJyBXf24
02 May 2016 News Simple Referral Rule May Lead to Earlier Referral and Diagnosis of Axial Spondyloarthritis
29 Apr 2016 Social Extensive skin psoriasis is a risk factor for Psoriatic Arthritis - other risk factors nail dz, obesity & smoking https://t.co/NZAqi0RJDB